Alliance Pharma Share News (APH)

EARNINGS: Alliance Pharma swings to profit; DG Innovate loss widens

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News:

Revenue, profits rise for Alliance Pharma

(Sharecast News) - Alliance Pharma reported a 2.8% increase in revenue on Monday, to £84.8m on a see-through basis, driven by the robust performance of its Kelo-Cote franchise.

UK earnings, trading statements calendar - next 7 days

EXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRx

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced in August so far and not separately reported by Alliance News:

IN BRIEF: Alliance Pharma trading in line, revenue edges higher

Alliance Pharma PLC - Chippenham, Wiltshire-based distributor of consumer healthcare brands and prescription medicines - Issues trading update for the six months to June 30. Expects revenue of GBP84.8 million, up 2.8% from GBP82.4 million a year prior. Consumer Healthcare revenues rise 5% to GBP61.4 million, prescription medicine revenues grows 3.4% to GBP23.3 million. Continues to expect group revenue to build throughout the second half, driving gross margin improvement which will be used to support further investment in marketing and innovation. Continues to anticipate that full-year profitability will be in line with financial 2023. Expects net debt and leverage to fall further in the second half, reflecting the group's strong cash generation.

Alliance Pharma flags solid rise in first-half revenue

(Sharecast News) - Alliance Pharma said in a half-year trading update on Monday that its revenue rose to £84.8m, a 2.8% increase year-on-year, and a 5% increase at constant exchange rates.

IN BRIEF: Alliance Pharma nixes chief operating officer role

Alliance Pharma PLC - Chippenham, Wiltshire-based distributor of consumer healthcare brands and prescription medicines - Says Chief Operating Officer Jeyan Heper will leave the business on August 31. Heper joined the group in February last year, and has been helping to identify growth opportunities in international consumer healthcare markets. Alliance Pharma explains that in order to accelerate the globalisation of the business, and to simplify the company's management structure, the board has decided that the role of COO is no longer a requirement at Alliance.

Alliance Pharma COO stepping down, position to be disestablished

(Sharecast News) - Healthcare products group Alliance Pharma announced on Tuesday that its chief operating officer Jeyan Heper would leave the company on 31 August.

UK shareholder meetings calendar - next 7 days

Alliance Pharma pays no dividend as board focus on reinvesting cash

(Alliance News) - Alliance Pharma PLC on Wednesday said the company generated "record sales" in 2023 on the back of a strong second-half performance.

Alliance Pharma posts strong results after audit delay

(Sharecast News) - Alliance Pharma reported strong preliminary results for the year ended 31 December on Wednesday, after an audit delay, driven by a robust second half that led to record sales and expanded underlying profit.

IN BRIEF: Alliance Pharma drops as CEO departs, delays results again

Alliance Pharma PLC - Chippenham, Wiltshire-based distributor of consumer healthcare brands and prescription medicines - Shares close down 14% in London on Wednesday, after Alliance Pharma says Chief Executive Officer Peter Butterfield has decided to leave the company "to pursue other business interests". Following a "comprehensive" search process, it appoints Nick Sedgwick as new CEO, starting on Monday next week. Sedgwick has 30 years experience in consumer health, Alliance Pharma says, most recently as regional director for UK & Ireland Consumer Health at Reckitt Benckiser Group PLC. Butterfield will remain with Alliance Pharma until June 30 to facilitate a "thorough" handover, it says. Butterfield joined the board in 2010 and became CEO in 2018.

Butterfield out, Sedgwick in as Alliance Pharma CEO

(Sharecast News) - Alliance Pharma announced a significant leadership transition on Wednesday, with chief executive Peter Butterfield stepping down from his role to pursue other business interests.

AIM WINNERS & LOSERS: Mobile Tornado wins deal; boohoo loss widens

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday: